Dose of Truth for Emerging Biopharma:
One Shot at Launch
An actionable guide for emerging biopharma to nail first-launch readiness—why the first 6 months matter, how to unify training, content, coaching, and AI roleplay, plus a blueprint, metrics, and case studies for confident, compliant field teams.
INTRODUCTION
CHAPTER 1
CHAPTER 2
CHAPTER 3
CHAPTER 4
CHAPTER 5
CHAPTER 6
CHAPTER 7
CHAPTER 8
CONCLUSION
Why Emerging Biopharmas Need a New Launch Model
The Economics of Drug Development: What’s at Stake
Why the First 6 Months Determine Long-Term Success
The Launch Readiness Gap: Challenges for Emerging Companies
A New Model: The Unified Launch Readiness Hub
Real-World Case Studies: What Good Looks Like
Solving the Modern Launch Enablement Gap
Measuring What Matters: The Readiness Signals That Predict Performance
Your Launch-in-a-Box Blueprint
Launch Like a Veteran
